These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31898555)

  • 1. Breaking the selectivity-uptake trade-off of photoimmunoconjugates with nanoliposomal irinotecan for synergistic multi-tier cancer targeting.
    Liang BJ; Pigula M; Baglo Y; Najafali D; Hasan T; Huang HC
    J Nanobiotechnology; 2020 Jan; 18(1):1. PubMed ID: 31898555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photochemical targeting of epidermal growth factor receptor: a mechanistic study.
    Savellano MD; Hasan T
    Clin Cancer Res; 2005 Feb; 11(4):1658-68. PubMed ID: 15746071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience.
    Glassman DC; Palmaira RL; Covington CM; Desai AM; Ku GY; Li J; Harding JJ; Varghese AM; O'Reilly EM; Yu KH
    BMC Cancer; 2018 Jun; 18(1):693. PubMed ID: 29945562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoliposomal irinotecan (Nal-IRI)-based chemotherapy after irinotecan -based chemotherapy in patients with pancreas cancer.
    Smith CJ; Bekaii-Saab TS; Cook KD; Eiring RA; Halfdanarson TR; Hanna M; Jin Z; Jochum JA; Ma WW; Mitchell JL; Pitot HC; Jatoi A
    Pancreatology; 2021 Mar; 21(2):379-383. PubMed ID: 33468394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First evidence for the antitumor activity of nanoliposomal irinotecan with 5-fluorouracil and folinic acid in metastatic biliary tract cancer.
    Taghizadeh H; Unseld M; Schmiderer A; Djanani A; Wilthoner K; Buchinger D; Prager GW
    Cancer Chemother Pharmacol; 2020 Jul; 86(1):109-115. PubMed ID: 32556829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of MM-398, nanoliposomal irinotecan (nal-IRI), in Ewing's family tumor xenografts is associated with high exposure of tumor to drug and high SLFN11 expression.
    Kang MH; Wang J; Makena MR; Lee JS; Paz N; Hall CP; Song MM; Calderon RI; Cruz RE; Hindle A; Ko W; Fitzgerald JB; Drummond DC; Triche TJ; Reynolds CP
    Clin Cancer Res; 2015 Mar; 21(5):1139-50. PubMed ID: 25733708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting cells that overexpress the epidermal growth factor receptor with polyethylene glycolated BPD verteporfin photosensitizer immunoconjugates.
    Savellano MD; Hasan T
    Photochem Photobiol; 2003 Apr; 77(4):431-9. PubMed ID: 12733655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multicenter Phase 1 Trial Evaluating Nanoliposomal Irinotecan for Heated Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery for Patients with Peritoneal Surface Disease.
    Choi M; Harper MM; Pandalai PK; Abdel-Misih SRZ; Patel RA; Ellis CS; Reusch E; Reynolds J; Vacchi-Suzzi C; Park JM; Georgakis GV; Kim J
    Ann Surg Oncol; 2023 Feb; 30(2):804-813. PubMed ID: 36344711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient fluid flow improves photoimmunoconjugate delivery and photoimmunotherapy efficacy.
    Sorrin AJ; Zhou K; May K; Liu C; McNaughton K; Rahman I; Liang BJ; Rizvi I; Roque DM; Huang HC
    iScience; 2023 Aug; 26(8):107221. PubMed ID: 37520715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended topoisomerase 1 inhibition through liposomal irinotecan results in improved efficacy over topotecan and irinotecan in models of small-cell lung cancer.
    Leonard SC; Lee H; Gaddy DF; Klinz SG; Paz N; Kalra AV; Drummond DC; Chan DC; Bunn PA; Fitzgerald JB; Hendriks BS
    Anticancer Drugs; 2017 Nov; 28(10):1086-1096. PubMed ID: 28857767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of TGF-β signalling in combination with nal-IRI plus 5-Fluorouracil/Leucovorin suppresses invasion and prolongs survival in pancreatic tumour mouse models.
    Hong E; Park S; Ooshima A; Hong CP; Park J; Heo JS; Lee S; An H; Kang JM; Park SH; Park JO; Kim SJ
    Sci Rep; 2020 Feb; 10(1):2935. PubMed ID: 32076068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiepitope HER2 targeting enhances photoimmunotherapy of HER2-overexpressing cancer cells with pyropheophorbide-a immunoconjugates.
    Savellano MD; Pogue BW; Hoopes PJ; Vitetta ES; Paulsen KD
    Cancer Res; 2005 Jul; 65(14):6371-9. PubMed ID: 16024640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicine developments in the treatment of metastatic pancreatic cancer: focus on nanoliposomal irinotecan.
    Ko AH
    Int J Nanomedicine; 2016; 11():1225-35. PubMed ID: 27099488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective co-encapsulation of doxorubicin and irinotecan for synergistic therapy using liposomes prepared with triethylammonium sucrose octasulfate as drug trapping agent.
    Liu J; Chi D; Pan S; Zhao L; Wang X; Wang D; Wang Y
    Int J Pharm; 2019 Feb; 557():264-272. PubMed ID: 30599233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraperitoneal photoimmunotherapy of ovarian carcinoma xenografts in nude mice using charged photoimmunoconjugates.
    Molpus KL; Hamblin MR; Rizvi I; Hasan T
    Gynecol Oncol; 2000 Mar; 76(3):397-404. PubMed ID: 10684717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immobilization of Photo-Immunoconjugates on Nanoparticles Leads to Enhanced Light-Activated Biological Effects.
    Huang HC; Pigula M; Fang Y; Hasan T
    Small; 2018 Jul; ():e1800236. PubMed ID: 29962083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of conventional versus liposomal irinotecan in combination with fluorouracil for advanced pancreatic cancer: a single-institution experience.
    Tossey JC; Reardon J; VanDeusen JB; Noonan AM; Porter K; Arango MJ
    Med Oncol; 2019 Sep; 36(10):87. PubMed ID: 31494781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study.
    Park SJ; Kim H; Shin K; Hong TH; Suh JH; Lee MA
    BMC Cancer; 2021 Nov; 21(1):1176. PubMed ID: 34732161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmenting Experimental Gastric Cancer Activity of Irinotecan through Liposomal Formulation and Antiangiogenic Combination Therapy.
    Awasthi N; Schwarz MA; Zhang C; Klinz SG; Meyer-Losic F; Beaufils B; Thiagalingam A; Schwarz RE
    Mol Cancer Ther; 2022 Jul; 21(7):1149-1159. PubMed ID: 35500018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of charge on the interaction of site-specific photoimmunoconjugates with human ovarian cancer cells.
    Hamblin MR; Miller JL; Hasan T
    Cancer Res; 1996 Nov; 56(22):5205-10. PubMed ID: 8912858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.